Bonne
- Two KOSDAQ Playbooks: L&C Bio's 140 Billion Won Rights Offer, Bonne's Private Placement
L&C Bio seeks about 140 billion won in a shareholder rights offering while Bonne raises 2.2 billion won from one investor — two KOSDAQ paths to new equity.